Study of Progesterone in Treatment of Vasomotor Symptoms
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- BHR Pharma, LLC
- Target Recruit Count
- 55
- Registration Number
- NCT03202186
- Locations
- 🇩🇪
Fachärztin für Gynäkologie und Geburtshilfe, Bernburg, Germany
Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2017-06-27
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- BHR Pharma, LLC
- Target Recruit Count
- 223
- Registration Number
- NCT03199963
- Locations
- 🇺🇸
Physician Care Clinical Research, LLC, Sarasota, Florida, United States
🇺🇸Aventiv Research, Inc., Columbus, Ohio, United States
🇺🇸USC-Keck Medical Center, Los Angeles, California, United States
Maintaining Suppression of Testosterone With Transdermal Estradiol Gel
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2015-01-28
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- BHR Pharma, LLC
- Target Recruit Count
- 34
- Registration Number
- NCT02349386
- Locations
- 🇺🇸
AccumetRX Clinical Trials, Albuquerque, New Mexico, United States
🇺🇸Urologic Consultants of Southeastern Pennsylvania (UCSEPA), Bala-Cynwyd, Pennsylvania, United States
🇺🇸Urological Associates of Southern Arizona, Tucson, Arizona, United States
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-06-14
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- BHR Pharma, LLC
- Target Recruit Count
- 1195
- Registration Number
- NCT01143064
- Locations
- 🇺🇸
University of South Alabama Medical Center, Mobile, Alabama, United States
🇺🇸LAC+USC Medical Center, Los Angeles, California, United States
🇺🇸University of California San Diego Medical Center, San Diego, California, United States
© Copyright 2024. All Rights Reserved by MedPath